[Event report] Fourth session of the Diet Study Group on Dementia (May 31, 2018)
date : 6/5/2018
Tags: Dementia, Diet Member Briefing
The non-partisan Diet Study Group on Dementia headed by House of Representatives member Hayato Suzuki held its fourth session. HGPI is currently providing planning and operations support for this study group. The fourth meeting was attended by Professor Takeshi Iwatsubo, an authority on Alzheimer’s Disease, which accounts for over half of all dementia cases.
Background
The number of people living with dementia in Japan is expected to rise alongside the aging of the population. Policies to deal with this challenge are urgently needed. Japan has taken up the challenge of such polices by launching the “New Orange Plan” – a comprehensive strategy to address dementia. However, additional measures on dementia will be needed in the future. To that end, a number of House of Representatives members have formed this voluntary, regular, non-partisan study group to encourage as many House of Representatives members as possible to become interested in this issue and knowledgeable about it.
Session presentations
“Frontline Research on Alzheimer’s Disease and Dementia”
Dr. Takeshi Iwatsubo (Professor at the Department of Neuropathology at the Graduate School of Medicine in the University of Tokyo; Chief of early-stage detection section at the University of Tokyo Hospital; Director of Japan Society for Dementia Research – Chief executive of basic research section; Chief researcher at J-ADNI)
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)
-
2025-12-16
[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)



